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The use of Boc2O as a coupling agent in the homologation of N-urethane protected-α-amino acid to its β-homomers
by the Arndt–Eistert method is described. The homologation gives good yields without racemization. The use of
Boc2O as a coupling agent not only allows the easy scale up of the process but also it is cost eﬀective.
Recently, unnatural polymers with well deﬁned folding pro-
pensities have attracted a great deal of attention.1 Oligomers of
β-amino acids (β-peptides) can adopt a variety of secondary
structures including helices,2 sheets 3 and reverse turns 4 depend-
ing upon the residue substitution pattern in organic solvents as
well as in the solid state. Furthermore, β-peptides are also
found to be chemically stable and resistant to enzymatic
degradation which may ultimately be useful for the construc-
tion of biomimetic polymers.5 It was recently demonstrated that
a β-amino acid analogue of Tat 47–57 translocates across
human cell membranes with eﬃciency comparable to HIV Tat
47–57 itself.6 Thus, peptides composed of β-amino acids hold
particular promise in molecular design.
β-Amino acids can be synthesized by homologation of
α-amino acids as well as by other routes.7 The homologation
of an α-amino acid to its higher homologue (β3-amino acid) can
be very conveniently carried out using the Arndt–Eistert
method in a two step process.8 The use of mixed anhydride
method 9 is now routinely employed, under careful conditions
for the synthesis of α-aminodiazoketone derivatives with
moderate yields. Unlike the acid chlorides,10 the utility of acid
ﬂuorides 11 and pentaﬂuorophenyl esters 12 led to not only
Fmoc-β-amino acids but also Boc- and Z-β-amino acids in
good yields. All these routes involve the activation of the car-
bonyl group of the urethane protected α-amino acid employing
either preformed, isolated, and activated derivatives or an in
situ generated, activated species for acylation of diazomethane.
Alternatively, the use of DCC and related coupling agents
like DIC, EDC, etc., as coupling agents has several advantages
including activation and acylation to be achieved in a single
step.13 Its employment in peptide synthesis is still particularly
relevant in the large scale production of peptides.14 However, its
use for the acylation of diazomethane resulted in only about
30–70% of Pht-/Z-/Boc-aminoacyldiazoketone.15
Results and discussion
As a part of our aim to ﬁnd the eﬀect of incorporation of
β-amino acids into the sequential bioelastic polypeptides 16 of
the repeating pentamers VPGVG, PGVGV, GVGVP, VGVGP,
GVPGV, etc., a cost eﬀective and eﬃcient approach to β-amino
acids was required. The use of Boc2O as a tert-butoxy car-
bonylating agent for the protection of amino groups,17 alcohols
and thiols,18 etc., and for the synthesis of six Boc-protected
dipeptide esters,19 etc., is well documented. This report deals
with its applicability in stereo speciﬁc homologation of com-
mercially available urethane protected α-amino acids to their
β-homomers.
It has been found that the reaction of diazomethane with
Boc-/Z-/Fmoc-α-amino acids could be carried out using Boc2O
at 0 C in the presence of an equimolar quantity of pyridine
and a catalytic amount of 4-dimethylaminopyridine (DMAP).
The reaction (Scheme 1) proceeds through the formation of a
carbonic–carbonic mixed anhydride which has been identiﬁed
by the characteristic carbonyl vibrational stretching frequency
of the anhydride at 1820 cm1 in the IR spectra. The addition
of DMAP results in formation of the reactive tert- butoxy-
carbonyl-4-dimethylaminopyridinium tert-butylcarbonate,
which facilitates the nucleophilic addition of the amino acid
carboxylate anion at the tert-butoxy carbonyl group of the
pyridinium system, and consequently activates the amino acid
carbonyl toward acylation of diazomethane. It is also observed
that the rate of reaction is sluggish in the absence of DMAP. A
freshly prepared 0.66 M solution of diazomethane in diethyl
ether was added to N α-protected amino acid, Boc2O, pyridine,
DMAP mixture in THF at 0 C, and then the reaction mixture
was stirred for 30 min and allowed to warm up to r.t. before
workup. The acylation reaction with two equivalents excess of
diazomethane results in complete conversion. The course of the
reaction was monitored by TLC using chloroform–methanol–
acetic acid (45 : 2 : 1, v/v/v) as well as using IR. All the resulting
Boc-/Z-/Fmoc-aminoacyldiazoketones (II a–i) are isolated as
crystalline solids in 85–94% yield. The purity of the com-
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pounds, as checked by HPLC, is satisfactory. They have been
fully characterized by using IR which contains characteristic
stretching vibrational frequencies at 2100–2108 cm1 of the
CHN2 group and by 
1H NMR.
The compounds II a–i were then converted to the corre-
sponding β-amino acids by Wolﬀ rearrangement using silver
benzoate–1,4-dioxane–water by reﬂuxing the mixture for 6 h
at 70 C. The resulting β-amino acids III a–i were also
characterized.
The acylation of diazomethane using Boc2O was found to be
free from racemization. This was conﬁrmed by comparing
the speciﬁc rotations of II f: [α]25D (c 1, CHCl3  60.4), III f:
[α]25D (c 1, CHCl3  24.2) and II g: [α]
25
D (c 1, CHCl3  60.14),
III g: [α]25D (c 1, CHCl3  24.8). Furthermore, the HPLC analysis
of II b (Rt for the -isomer 17.48 min, Rt for racemic mixture
17.44 min and 18.18 min) and III b (Rt for the -isomer
15.42 min, Rt for racemic mixture 15.36 min and 16.12 min)
derived from Fmoc-Val-OH and comparison with the analysis
of racemic mixture speciﬁcally prepared to test the possible
extent of racemization reveals that both acylation of diazo-
methane using Boc2O and Wolﬀ rearrangement are free from
racemization.
Thus, Boc2O, a commonly used reagent for the introduction
of the Boc group in peptide synthesis, can also conveniently be
used for the homologation of urethane protected α-amino acids
to β-amino acids with good yield and without racemization. In
contrast to the method with DCC, the removal of side products
(CO2 and 
tBuOH) in the present method poses no practical
problems. This is a simple procedure, which allows the easy
scale up of the process to make large quantities of β-amino
acids.
Experimental
All the solvents were freshly distilled prior to use. Melting
points were recorded by capillary method and are uncorrected.
TLC analysis was carried out on precoated silica gel plates using
solvent system chloroform–methanol–acetic acid (45 : 2 : 1,
v/v/v). IR spectra were recorded on a Nicolet model impact
400D FT-IR spectrometer (KBr pellets). HPLC analysis was
performed with a Waters LC-3000 system consisting of a
484 tunable absorbance UV detector and a Millipore 745
data modulae using a C18 Bondapack (3.9 × 300 mm, 10µ)
and chiralcel OD (4.6 × 250 mm, 10µ) columns with a linear
gradient of water (0.1% TFA) and acetonitrile (0.1% TFA),
with acetonitrile from 20% to 90% over 25 min. Optical
rotations were determined using automatic AA-10 polarimeter
(Optical Activity, UK) and are given in 101 deg cm2 g1.
Elemental analyses were carried out on a Perkin-Elmer
analyzer. 1H NMR spectra were recorded using a Bruker AMX
400 MHz spectrometer. The diazomethane solution in dry
diethyl ether was prepared from N-methyl-N-nitrosotoluene-p-
sulfonamide using a reported procedure.20,21 The concentration
of diazomethane solution was estimated by back-titration with
benzoic acid solution.22
General procedure for the synthesis of N -urethane protected
aminodiazoketone
To a stirred solution of N α-protected amino acid (5 mmol),
pyridine (0.4 mL, 5 mmol), Boc2O (1.05 g, 5.5 mmol) and
a catalytic amount of DMAP (0.012 g) in THF (15 mL),
diazomethane in diethyl ether (15 mL) was added at 0 C and
stirred for about 30 min. The solvent was evaporated and the
residue was dissolved in CHCl3. It was washed thrice using
5 mL portions of 5% NaHCO3, 5% HCl or citric acid and
water, and then the organic phase was dried over anhydrous
Na2SO4. Evaporation of the solvent under reduced pressure
and recrystallization of the resulting residue from hexane gave
the title compound as a crystalline solid.
Fmoc-glycyldiazomethane (II a). 1.5 g (5 mmol) of I a, after
the reaction gave 1.44 g (89%) of II a; mp 148 C; Anal. Calc.
for C18H15N3O3 (321.29): C, 67.28; H, 4.67; N, 13.08; Found C,
67.35; H, 4.62; N, 13.15%; IR νmax. cm
1 2104 (CHN2), 1690
(CO urethane); 1H NMR (δ, CDCl3): 2.7 (2H, t), 4.25 (1H,
J = 6.5, t), 4.60 (2H, d), 5.42 (1H, d), 5.5 (1H, J = 8.3, d) and
7.26–7.8 (8H, m).
Fmoc-L-valyldiazomethane (II b). 1.70 g (5 mmol) of I b, after
the reaction gave 1.72 g (94%) of II b; mp 123–124 C; Anal.
Calc. for C21H21N3O3 (365.42): C, 69.41; H, 5.81; N, 11.56;
Found C, 69.48; H, 5.82; N, 11.65%; IR νmax. cm
1 2106
(CHN2), 1690 (CO urethane); 
1H NMR (δ, CDCl3): 0.90 (3H,
J = 6.5, d), 1.10 (3H, J = 6.5, d), 2.15 (1H, m), 4.10 (1H, m),
4.25 (1H, J = 6.6, t), 4.4 (2H, d), 5.25 (1H, s), 5.4 (1H, d)
and 7.30–7.8 (8H, m).
Fmoc-L-aspartyl-(OtBu)-diazomethane (II c). 2.05 g (5 mmol)
of I c, after the reaction gave 1.92 g (88%) of II c; mp 73 C;
Anal. Calc. for C24H25N3O5 (435.42): C, 66.20; H, 5.74; N, 9.65;
Found C, 66.28; H, 5.64; N, 9.73%; IR νmax. cm
1 2105 (CHN2),
1745 (OtBut), 1703 (CO urethane); 1H NMR (δ, CDCl3): 1.4
(9H, s), 2.0 (1H, m), 2.45 (2H, m), 4.32 (2H, d), 4.5 (1H, J = 6.6,
m), 5.4 (1H, s), 5.5 (1H, J = 7.8, d) and 7.3–7.8 (8H, m).
Fmoc-L-lysyl-(N Boc)-diazomethane (II d). 2.34 g (5 mmol)
of I d, after the reaction gave 2.23 g (90.6%) of II d; mp 96 C;
Anal. Calc. for C27H32N4O5 (492.52): C, 65.8; H, 6.54; N, 11.37;
Found C, 64.86; H, 6.64; N, 11.45%; IR νmax. cm
1 2106
(CHN2), 1700, 1690 (CO urethanes); 
1H NMR (δ, CDCl3): 1.3
(9H, s), 2.22 (8H, m), 4.16 (2H, J = 6.5, t), 4.24 (2H, d), 5.25
(1H, s), 5.63 (1H, br), 6.0 (1H br) and 7.25–7.8 (8H, m).
Boc-L-prolyldiazomethane (II e). 1.075 g (5 mmol) of I e, after
the reaction gave 1.03 g (86%) of II e; mp 44 C; Anal. Calc. for
C11H17N3O3 (239.24): C, 55.22; H, 7.5; N, 17.56; Found C,
55.68; H, 7.34; N, 17.48%; IR νmax. cm
1 2105 (CHN2), 1690
(CO urethane); 1H NMR (δ, CDCl3): 1.4 (9H, s), 2.4 (4H, m),
3.45 (2H, t), 4.2 (1H, q) and 5.30 (1H, s).
Boc-L-isoleucyldiazomethane (II f ). 1.55 g (5 mmol) of I f,
after the reaction gave 1.12 g (87.8%) of II f; mp 86 C; Anal.
Calc. for C12H21N3O3 (255.28): C, 56.45; H, 8.28; N, 16.45;
Found C, 56.28; H, 8.34; N, 16.48%; IR νmax. cm
1 2107
(CHN2), 1700 (CO urethane); 
1H NMR (δ, CDCl3): 0.9 (3H,
J = 7.5, t), 0.93 (3H, J = 7.1, d), 1.32 (11H, m), 1.5 (1H, m), 4.24
(1H, m), 5.3 (1H, s) and 5.42 (1H, J = 8.3, d).
Boc-D-isoleucyldiazomethane (II g). 1.55 g (5 mmol) of I g,
after the reaction gave 1.18 g (92.5%) of II g; mp 85–86 C;
Anal. Calc. for C12H21N3O3 (255.28): C, 56.45; H, 8.28; N,
16.45; Found C, 56.32; H, 8.30; N, 16.50%; IR νmax. cm
1 2107
(CHN2), 1700 (CO urethane); 
1H NMR (δ, CDCl3): 0.9 (3H,
J = 7.5, t), 0.93 (3H, J = 7.1, d), 1.3 (11H, m), 1.55 (1H, m), 4.24
(1H, m), 5.35 (1H, s) and 5.45 (1H, J = 8.3, d).
Z-L-phenylalanyldiazomethane (II h). 1.5 g (5 mmol) of I h,
after the reaction gave 1.54 g (95%) of II h; mp 82 C; Anal.
Calc. for C18H17N3O3 (315.30): C, 66.86; H, 5.29; N, 12.99;
Found C, 66.3; H, 5.8; N, 13.28%; IR νmax. cm
1 2107 (CHN2),
1700 (CO urethane); 1H NMR (δ, CDCl3): 2.9 (2H, d), 4.6 (1H,
m), 5.05 (2H, s), 5.1 (1H, s), 5.4 (1H, J = 5.9, d) and 7.3–7.8
(10H, m).
Z-L-phenylglycyldiazomethane (II i). 1.45 g (5 mmol) of I i,
after the reaction gave 1.38 g (89%) of II i; mp 88 C; Anal.
Calc. for C17H15N3O3 (309.27): C, 66.01; H, 4.88; N, 13.58;
Found C, 66.08; H, 4.9; N, 13.60%; IR νmax. cm
1 2106 (CHN2),
1690 (CO urethane); 1H NMR (δ, CDCl3): 4.5 (1H, br), 5.03
(2H, s), 5.3 (1H, s), 5.42 (1H, J = 5.8, d) and 7.3 (10H, m).
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General procedure for the synthesis of N -protected--homo-
amino acids
N α-Protected aminoacyldiazoketone (II a–i) (5 mmol) in 1,4-
dioxane (15 mL) and water (10 mL) was treated with silver
benzoate (20 mg, 0.08 mmol). The reaction mixture was
reﬂuxed at 70 C for 6 h and then ﬁltered. The solvent was
evaporated under reduced pressure. The residue was dissolved
in saturated aqueous Na2CO3 solution (50 mL) and stirred,
the mixture was washed with diethyl ether (3 × 30 mL). The
aqueous layer was acidiﬁed to pH 2 using HCl–citric acid and
extracted using EtOAc (3 × 30 mL). The organic layer was
washed with water, dried over Na2SO4 and evaporated to get the
title compound in good yield.
Fmoc--homoglycine (III a). 1.625 g (5 mmol) of II a, after
the rearrangement gave 1.26 g (80%) of III a; mp 148 C; Anal.
Calc. for C18H17NO4 (311.29): C, 69.45; H, 5.46; N, 4.50; Found
C, 69.52; H, 5.42; N, 4.58%; 1H NMR (δ, CDCl3): 2.75 (2H, t),
3.46 (2H, m), 4.3 (1H, J = 6.6, t), 4.6 (2H, d), 5.52 (1H, J = 8.4,
d), 7.2–7.8 (8H, m) and 8.6 (1H, br).
Fmoc-L--homovaline (III b). 1.826 g (5 mmol) of II b, after
the rearrangement gave 1.35 g (76%) III b; mp 155 C; Anal.
Calc. for C21H23NO4 (353.38): C, 70.14; H, 5.89; N, 4.30; Found
C, 70.23; H, 5.76; N, 4.38%; 1H NMR (δ, CDCl3): 0.9 (6H,
J = 6.2, d), 1.8 (1H, m), 2.32 (1H, d), 2.45 (1H, d), 3.8 (1H, m),
4.2 (1H, J = 6.6, t), 4.42 (2H, J = 6.6, d), 5.9 (1H, J = 9.2, d)
and 7.3–7.8 (8H, m).
Fmoc-L--homoaspartic(OtBu) acid (III c). 2.175 g (5 mmol)
of II c, after the rearrangement gave 1.684 g (79%) of III c; mp
85 C; Anal. Calc. for C24H27NO6 (425.41): C, 67.76; H, 6.35; N,
3.29; Found C, 67.64; H, 6.48; N, 3.43%; 1H NMR (δ, CDCl3):
1.4 (9H, s), 2.6 (2H, J = 5.2, d), 2.73 (2H, d), 4.2 (1H, t), 4.4
(3H, m), 6.5 (1H, J = 9.2, d) and 7.2–7.8 (8H, m).
Fmoc-L--(N -Boc)-homolysine (III d). 2.462 g (5 mmol) of
II d, after the rearrangement gave 1.82 g (75%) of III d; mp
95 C; Anal. Calc. for C27H34N2O6 (482.52): C, 64.6; H, 6.53; N,
5.38; Found C, 64.42; H, 6.48; N, 5.32%; 1H NMR (δ, CDCl3):
1.5 (9H, s), 2.1 (8H, m), 2.32 (2H, J = 5.0, d), 2.45 (1H, d), 4.2
(1H, J = 6.8, t), 4.35 (2H, d), 5.62 (1H, br) and 7.25–7.8
(9H, m).
Boc-L--homoproline (III e). 1.195 g (5 mmol) of II e, after
the rearrangement gave 0.92 g (80%) of III; gum; Anal. Calc.
for C11H19NO4 (229.23): C, 57.87; H, 8.38; N, 6.13; Found C,
57.64; H, 8.58; N, 5.92%; 1H NMR (δ, CDCl3): 1.30 (9H, s), 2.0
(4H, m), 2.4 (2H, d), 3.42 (2H, t), 3.85 (1H, m) and 8.3 (1H, br).
Boc-L--homoisoleucine (III f ). 1.275 g (5 mmol) of II f, after
rearrangement gave 0.98 g (80%) of III f; mp 86 C; Anal. Calc.
for C12H23NO4 (245.28): C, 58.99; H, 9.48; N, 5.73; Found C,
58.86; H, 9.56; N, 5.68%; 1H NMR (δ, CDCl3): 0.9 (3H, J = 7.2,
t), 0.93 (3H, J = 6.8, d), 1.32 (11H, m), 1.5 (1H, m), 2.35 (2H, d),
3.5 (1H, m), 5.4 (1H, br) and 8.3 (1H, br).
Boc-D--homoisoleucine (III g). 1.275 g (5 mmol) of II g, after
rearrangement gave 1.02 g (83%) III g; mp 87 C; Anal. Calc.
for C12H23NO4 (245.28): C, 58.99; H, 9.48; N, 5.73; Found C,
58.92; H, 9.52; N, 5.8%; 1H NMR (δ, CDCl3): 0.89 (3H, J = 7.2,
d), 0.92 (3H, J = 6.8, d), 1.32 (11H, m), 1.5 (1H, m), 2.3 (2H, d),
3.55 (1H, m), 5.42 (1H, br) and 8.32 (1H, br).
Z-L--homophenylalanine (III h). 1.62 g (5 mmol) of II h,
after rearrangement gave 1.32 g (84%) of III h; mp 84 C; Anal.
Calc. for C18H19NO4 (313.31): C, 69.21; H, 6.13; N, 4.48; Found
C, 68.92; H, 6.18; N, 4.35%; 1H NMR (δ, CDCl3): 2.30 (2H, d),
2.75 (2H, d), 3.82 (1H, m), 5.01 (2H, s), 5.28 (1H, J = 5.9, d),
7.10 (5H, s), 7.28 (5H, s) and 9.4 (1H, br).
Z-L--homophenylglycine (III i). 1.55 g (5 mmol) of II i, after
rearrangement gave 1.2 g (82%) of III i; mp 86–88 C; Anal.
Calc. for C17H17NO4 (303.27): C, 68.44; H, 5.74; N, 4.95; Found
C, 68.32; H, 5.82; N, 5.02%; 1H NMR (δ, CDCl3): 2.5 (2H, d),
4.3 (1H, m), 5.02 (2H, s), 5.4 (1H, J = 5.8, d), 7.2 (10H, s) and
8.6 (1H, br).
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